{"id":"tp-30236","type":"article-newspaper","title":"Bristol Myers Squibb Shares Rise After Two Late-Stage Trials Deliver Results","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/30236","datePublished":"2026-10-12T11:22:54.000Z","dateModified":"2026-10-12T11:22:54.000Z","language":"en","abstract":"The ALOFT-IPF trial of admilparant in adults with idiopathic pulmonary fibrosis met its primary endpoint.","section":"Business","references":[]}